Naltrexone and bupropion for weight loss

被引:0
|
作者
Thomas, Betsy [1 ]
Lindblad, Adrienne J. [1 ]
Luu, Thao [2 ]
Paige, Allison [3 ,4 ]
机构
[1] Univ Alberta, Dept Med Familiale, Edmonton, AB, Canada
[2] Univ Alberta, Pharm, Edmonton, AB, Canada
[3] Hop Gen Seven Oaks, Ctr Med Kildonan, Winnipeg, MB, Canada
[4] Univ Manitoba, Winnipeg, MB, Canada
关键词
D O I
10.46747/cfp.6909e179
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:E179 / E180
页数:2
相关论文
共 50 条
  • [21] Naltrexone/bupropion: Contrave®; Naltrexone SR/bupropion SR
    不详
    Drugs in R & D, 2010, 10 (1) : 25 - 32
  • [22] Naltrexone/Bupropion
    不详
    DRUGS IN R&D, 2010, 10 (01) : 25 - 32
  • [23] Naltrexone/Bupropion extended release-induced weight loss is independent of nausea in subjects without diabetes
    Hong, K.
    Herrmann, K.
    Dybala, C.
    Halseth, A. E.
    Lam, H.
    Foreyt, J. P.
    CLINICAL OBESITY, 2016, 6 (05) : 305 - 312
  • [24] A Case of Chronic Eosinophilic Pneumonia Associated With the Use of Weight Loss Combination Medication Naltrexone-Bupropion
    Schuldt, Anastasia
    Najmuddin, Asif
    Sharma, Munish
    Surani, Salim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [25] Weight Loss Mediates the Treatment Effect of Naltrexone/Bupropion on Glycemic Control in Patients with Type 2 Diabetes
    Hollander, Priscilla A.
    Plodkowski, Ray
    Shan, Kevin
    Gilder, Kye
    Halseth, Amy
    DIABETES, 2017, 66 : A557 - A557
  • [26] Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study
    Naude, James
    Zentner, Ali
    Suresh, Priya
    Bittman, Jesse
    Khan, Nadia A.
    INTERNATIONAL JOURNAL OF OBESITY, 2024, 48 (08) : 1118 - 1125
  • [27] The real-world relationship between naltrexone/bupropion treatment and weight loss in Canada: A retrospective chart review
    Wharton, Sean
    Kamran, Elham
    Thabane, Lehana
    Yin, Peter
    Christensen, Rebecca
    CLINICAL OBESITY, 2024,
  • [28] Naltrexone plus Bupropion Combination Causes Significant Weight Loss: A 56-Week Phase 3 Study
    Wadden, Thomas
    Klein, Samuel
    Greenway, Frank L.
    Erickson, Janelle
    Kim, Dennis D.
    Dunayevich, Eduardo
    Pl-Sunyer, F. Xavier
    DIABETES, 2009, 58 : A10 - A10
  • [29] Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight
    McIntyre, Roger S.
    Paron, Emilia
    Burrows, Melonie
    Blavignac, Jessica
    Gould, Errol
    Camacho, Fernando
    Barakat, Maxime
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 289 : 167 - 176
  • [30] Early Achievement of Significant Weight Loss with Naltrexone/Bupropion Is Associated with Additional Weight Loss and Improved Glycemic Control at One Year in Patients with Type 2 Diabetes
    Plodkowski, Ray
    Hollander, Priscilla A.
    Acevado, Lisette
    Gilder, Kye
    Halseth, Amy
    DIABETES, 2017, 66 : A557 - A557